Journal of Natural Products
Article
added, and the mixture was stirred at 0 °C for 6 h. The mixture was
quenched by addition of a saturated solution of Rochelle’s salt (5 mL)
and stirred at room temperature for 2 h. After dilution of the mixture
with EtOAc (10 mL), the phases were separated and the aqueous
layer was extracted with Et2O (2 × 25 mL). The combined organic
extract was washed once with 20 mL of saturated aqueous NaCl, dried
over anhydrous Na2SO4, and concentrated under reduced pressure.
Purification of the residue by flash chromatography (SiO2, 10:1 → 3:1
hexanes/EtOAc) afforded alcohol (4S,6S)-7 (76.4 mg, 0.33 mmol,
63%) or (4R,6R)-7 (70.3 mg, 0.31 mmol, 58%). (4S,6S)-7 (as a
mixture of carbamate rotamers): 1H NMR (400 MHz, CDCl3) δ 5.13
(br s, 1H), 4.15 (m, 1H), 3.71 (m, 1H), 3.29 (t, J = 5.8 Hz, 2H),
1.96−1.82 (m, 3H), 1.58 (m, 1H), 1.44 (s, 9H), 1.17 (d, J = 6.2 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 156.5, 79.8, 63.8, 53.7, 46.5,
45.5, 31.1, 28.4, 23.5, 22.5; HRMS (ESI) calculated for
mixture was allowed to warm to room temperature and stir overnight.
CH2Cl2 (10 mL) and a saturated solution of NaHCO3 were added
(10 mL), and the layers were separated. The aqueous layer was
extracted with EtOAc (2 × 25 mL). The combined organic extract
was washed once with 20 mL of saturated aqueous NaCl, dried over
anhydrous Na2SO4, and concentrated under reduced pressure.
Purification of the residue by flash chromatography (SiO2, 5:1
hexanes/EtOAc → 2:1 hexanes/EtOAc) afforded the four diaster-
eomers (4S,6S)-1, (4R,6R)-1, (4S,6R)-1, and (4R,6S)-1. (4S,6R)-1
1
(101 mg, 0.344 mmol, 51%, as a mixture of amide rotamers): H
NMR (400 MHz, CDCl3) δ 6.89 (m, 1H), 4.99 (m, 1H), 4.20, 3.85
(m, 1H), 3.47−3.40 (m, 2H), 2.31 (t, J = 7.6 Hz, 1H), 2.21 (t, J = 8.1
Hz, 1H), 1.89−1.75 (m, 5H), 1.77 (s, 3H), 1.74 (d, J = 7.0 Hz, 3H),
1.64 (m, 2H), 1.44 (m, 1H), 1.27 (d, J = 6.2 Hz, 3H), 1.27−1.24 (m,
12H), 0.86 (t, J = 6.7 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
171.8, 167.8, 137.4, 137.1, 128.8, 128.6, 68.5, 68.3, 54.4, 53.8, 46.7,
45.3, 41.8, 39.2, 35.1, 34.3, 31.8, 30.1, 29.6, 29.5, 29.4, 29.3, 29.2,
25.5, 24.8, 23.9, 22.6, 21.8, 20.9, 20.5, 14.4, 14.0, 12.1, 12.0; HRMS
(ESI) calculated for C22H40NO3 366.2990, found 366.2958 (M +
C12H23NNaO3 252.1576, found 252.1555 (M + Na)+; [α]25
=
D
−5.8 (c 0.01, CHCl3). These data are in full accord with those
reported for (4S,6S)-7.7 (4R,6R)-7 (as a mixture of carbamate
rotamers): 1H NMR (400 MHz, CDCl3) 4.16 (m, 1H), 3.72 (m, 1H),
3.30 (m, 2H), 1.99−1.85 (m, 3H), 1.60 (m, 1H), 1.47 (s, 9H), 1.40
(m, 2H), 1.18 (d, J = 6.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
156.5, 79.8, 63.7, 53.8, 46.4, 45.6, 31.1, 28.4, 23.4, 22.6; HRMS (ESI)
calculated for C12H23NNaO3 252.1576, found 252.1478 (M + Na)+;
H)+; [α]25 = −9.9 (c 0.01, MeOH). (4S,6S)-1 (84 mg, 0.28 mmol,
D
43%, as a mixture of amide rotamers): 1H NMR (400 MHz, CDCl3) δ
6.82 (m, 1H), 4.96 (q, J = 6.4 Hz, 1H), 4.08, 3.83 (m, 1H), 3.38 (m,
2H), 2.21 (t, J = 8.3 Hz, 2H), 2.08 (m, 1H), 1.91−1.78 (m, 9H),
1.66−1.58 (m, 3H), 1.31−1.25 (m, 16H), 0.88 (t, J = 6.7 Hz, 3H);
13C NMR (100 MHz, CDCl3) δ 171.6, 167.5, 136.7, 129.0, 69.6, 54.9,
46.6, 39.3, 35.0, 31.8, 29.5, 29.4, 29.2, 24.7, 24.1, 22.6, 20.0, 14.2,
14.0, 11.9; HRMS (ESI) calculated for C22H39NNaO3 388.2828,
[α]25 = +7.5 (c 0.02, CHCl3). These data are in full accord with
D
those reported for (4R,6R)-7.7
(2S)-tert-Butyl 2-[(2R)-2-Hydroxypropyl]pyrrolidine-1-carboxy-
late [(4S,6R)-8] and (2R)-tert-Butyl 2-[(2S)-2-Hydroxypropyl]-
pyrrolidine-1-carboxylate [(4R,6S)-8]. Ketone (4S)-6 or (4R)-6
(320 mg, 1.41 mmol) was dissolved in THF (5 mL), and the mixture
was cooled to −78 °C; LiAlH(OtBu)3 (1.07 g, 4.24 mmol, 3 equiv)
was added, and the mixture was warmed to 0 °C and stirred at this
temperature for 6 h. The mixture was quenched with a few drops of
water and diluted with EtOAc (10 mL). The solution was cooled to 0
°C, filtered through Celite, and concentrated in vacuo. Purification of
the residue by flash chromatography (SiO2, 10:1 → 3:1 hexanes/
EtOAc) afforded alcohol (4S,6R)-8 (293 mg, 1.28 mmol, 91%) or
(4R,6S)-8 (267 mg, 1.17 mmol, 83%). (4S,6R)-8 (as a mixture of
found 388.2838 (M + Na)+; [α]25 = −38.5 (c 0.01, MeOH).
D
(4R,6S)-1 (110 mg, 0.37 mmol, 56%, as a mixture of amide rotamers):
1H NMR (400 MHz, CDCl3) δ 6.90 (m, 1H), 5.00 (m, 1H), 4.20,
3.85 (m, 1H), 3.47−3.38 (m, 2H), 2.28 (t, J = 7.8 Hz, 1H), 2.25 (t, J
= 7.1 Hz, 2H), 1.91−1.76 (m, 9H), 1.64 (m, 2H), 1.44 (m, 1H),
1.41−1.27 (m, 16H), 0.89 (t, J = 6.6 Hz, 3H); 13C NMR (100 MHz,
CDCl3) δ 171.8, 167.8, 137.3, 128.8, 68.5, 54.4, 53.8, 46.7, 45.3, 41.8,
39.2, 35.1, 34.3, 31.8, 30.1, 29.6, 29.5, 29.4, 29.3, 25.5, 24.8, 23.9,
22.6, 21.8, 20.9, 20.5, 14.4, 14.0, 12.1; HRMS (ESI) calculated for
C22H40NO3 366.2990, found 366.3042 (M + H)+; [α]25 = +8.0 (c
1
D
carbamate rotamers): H NMR (400 MHz, CDCl3) 3.95 (br s, 1H),
0.01, MeOH). (4R,6R)-1 (70 mg, 0.19 mmol, 29%, as a mixture of
amide rotamers): 1H NMR (400 MHz, CDCl3) δ 6.82 (q, J = 4.3 Hz,
1H), 4.96 (q, J = 4.0 Hz, 1H), 4.08 (m, 1H), 3.41−3.35 (m, 2H), 2.21
(t, J = 8.1 Hz, 2H), 2.08 (m, 1H), 1.91−1.80 (m, 6H), 1.78 (d, J = 8.0
Hz, 3H), 1.64 (m, 3H), 1.32−1.30 (m, 13H), 1.31 (d, J = 8.0 Hz,
3H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 171.6,
167.5, 136.7, 129.0, 69.6, 54.9, 46.6, 39.3, 35.1, 31.8, 29.5, 29.2, 24.7,
24.1, 22.6, 20.0, 14.3, 14.0, 12.0; HRMS (ESI) calculated for
C22H39NaO3 388.2828, found 388.2832 (M + Na)+; [α]25D = +25.7 (c
0.03, MeOH). These data are in accord with those reported for
conioidine A.1
Competitive Ethidium Bromide Displacement Experiments.
Constant concentrations of CT-DNA (10 μM) and EtBr (10 μM)
(each in Tris-HCl buffer, pH 6.81) were titrated with increasing
concentrations of the diastereomers of 1 (from 1 mM and 100 μM
stock solutions in Tris-HCl buffer, pH 6.81) or netropsin. The
maximum emission wavelength was 490 nm when the excitation
wavelength was 520 nm. Fluorescence titrations were recorded from
520 to 692 nm after an equilibration period of 3 min: ex slit (nm) =
10.0; em slit (nm) = 10.0; scan speed (nm/min) = 200.
Thermal Denaturation Studies. UV thermal denaturation
samples (2 mL) were prepared by mixing CT-DNA in Tris-HCl
buffer (pH 6.81) in 1 cm path length quartz cuvettes. The DNA to
ligand ratio was 40:1. Absorbance readings were taken at 260 nm for
temperatures ranging from 25 to 95 °C. Temperature was increased
gradually with a speed of 1 °C/min with an absorbance reading every
2 °C. First derivative plots were used to determine the TM value.
ECD Studies. Small aliquots (0.6−5.0 μL) of a concentrated
(4R,6S)-1 solution (1 mM) were added to a solution of HSA (15 μM
in pH = 6.81 in Tris-HCl buffer), inverted twice, and incubated for 5
min at 20 °C. The ECD spectra were recorded as an average of three
scans from 220 to 310 nm, and data recorded in 0.1 nm increments.
3.80 (m, 1H), 3.30 (m, 2H), 1.97 (m, 1H), 1.81 (m, 2H), 1.62 (m,
1H), 1.42 (s, 9H), 1.16 (d, J = 5.0 Hz, 3H); 13C NMR (100 MHz,
CDCl3) 155.4, 79.5, 66.3, 55.5, 46.3, 45.3, 32.1, 28.4, 23.9, 23.7;
HRMS (ESI) calculated for C12H23NNaO3 252.1576, found 252.1597
(M+Na)+; [α]25 = −24.8 (c 0.08, CHCl3). These data are in full
D
accord with those reported for (4S,6R)-8.7 (4R,6S)-8 (as a mixture of
1
carbamate rotamers): H NMR (400 MHz, CDCl3) 3.89 (br s, 1H),
3.65 (m, J = 2.9 Hz, 1H), 3.62 (br s, 1H), 3.24 (m, 2H), 1.91−1.86
(m, 1H), 1.74 (m, 3H), 1.59 (m, 1H), 1.37 (s, 9H), 1.12 (d, J = 6.2
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 155.2, 79.4, 66.0, 55.2,
46.2, 44.9, 31.7, 28.4, 23.9, 23.7; HRMS (ESI) calculated for
C12H23NNaO3 252.1576, found 252.1579 (M + Na)+; [α]25D = +33.3
(c 0.02, CHCl3). These data are in full accord with those reported for
(4R,6S)-8.7
(4S,6S)-Conioidine A, (4R,6R)-Conioidine A, (4R,6S)-Conioidine
A, and (4S,6R)-Conioidine A. Alcohol (4S,6S)-7, (4R,6R)-7, (4S,6R)-
8, or (4R,6S)-8 (150 mg, 0.66 mmol) was dissolved in 1:1 TFA/
CH2Cl2 (1.5 mL) at room temperature, and the mixture was stirred
for 30 min, at which time it was concentrated in vacuo. The crude
residue was azeotroped with benzene (5 mL) twice, and CH2Cl2 (1.5
mL) was added. Et3N (0.25 mL, 1.6 mmol) was added, and the
mixture was cooled to 0 °C. Decanoyl chloride (0.15 mL, 0.72 mmol)
was added dropwise, and the mixture was warmed to room
temperature and stirred overnight. A solution of saturated NaHCO3
(5 mL) was added, and the layers were separated. The aqueous layer
was extracted with EtOAc (2 × 25 mL). The combined organic
extract was washed once with 20 mL of saturated aqueous NaCl, dried
over anhydrous Na2SO4, and concentrated under reduced pressure.
The crude intermediate alcohol (∼189 mg, 0.67 mmol) was dissolved
in CH2Cl2 (2 mL) and cooled to 0 °C. Pyridine (0.216 mL, 2.68
mmol), DMAP (163 mg, 1.34 mmol), and 2,3-dimethylacryloyl
chloride (158 mg, 1.34 mmol) were added successively, and the
F
J. Nat. Prod. XXXX, XXX, XXX−XXX